Organovo Holdings, Inc. (NASDAQ:ONVO) went up to recover about 22.22% since recording its record low price of $0.9. The stock experienced 3.77% jump, arriving at $1.1 on 01/09/2019. During the day, the stock price traveled from $1.07 to $1.1. This company shares are 127.27% off its target price of $2.5 and the current market capitalization stands at $126.23M. The recent change has given its price a 7.03% lead over SMA 50 and -47.37% deficit over its 52-week high. The stock witnessed 6.8% gains, -0.9% declines and -21.99% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found ONVO’s volatility during a week at 4.19% and during a month it has been found around 5.68%.Organovo Holdings, Inc. (ONVO) Top Holders
Institutional investors currently hold around $45 million or 36.7% in ONVO stock. Look at its top three institutional owners. Ark Investment Management Llc owns $19.03 million in Organovo Holdings, Inc., which represents roughly 15.07% of the company’s market cap and approximately 42.28% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 7,068,897 shares of the stock are valued at $7.49 million. The third largest holder is Vanguard Group Inc, which currently holds $5.06 million worth of this stock and that ownership represents nearly 4.01% of its market capitalization.
At the end of September reporting period, 50 institutional holders increased their position in Organovo Holdings, Inc. (NASDAQ:ONVO) by some 4,714,588 shares, 34 decreased positions by 458,635 and 43 held positions by 36,962,634. That puts total institutional holdings at 42,135,857 shares, according to SEC filings. The stock grabbed 15 new institutional investments totaling 279,449 shares while 11 institutional investors sold out their entire positions totaling 101,198 shares.Organovo Holdings, Inc. (NASDAQ:ONVO) Insider Trades
Multiple company employees have indulged in significant insider trading. Organovo Holdings, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Scientific Officer Presnell Sharon Collins has sold 40,000 shares of Organovo Holdings, Inc. (ONVO) in trading session dated Nov. 08, 2018. These shares are worth $50,800 and were traded at $1.27 each. The SEC filing shows that Murphy Keith performed a purchase of 335,500 shares. The Former affiliate last filing added these shares by way of transaction on Nov. 24, 2017. The company’s shares were assimilated at $1.49 per share worth to an investment of some $499,895 on account of Murphy Keith.
Chairman, CEO and President, Murphy Keith, sold 25,000 common shares of Organovo Holdings, Inc. (ONVO) in the open market. In a transaction dated Feb. 09, 2017, the shares were put up for sale at an average price of $3.68, raking in a sum of $92,000. After this sale, 12,112,830 common shares of ONVO are directly owned by the insider, with total stake valued at $13,324,113.
In the transaction dated Jan. 24, 2017, the great number of shares disposed came courtesy the Chairman, CEO and President; Murphy Keith disposed a total of 25,000 shares at an average price of $3.51, amounting to approximately $87,750. The insider now directly owns 6,038,915 shares worth $6,642,807.
Several analysts have released their opinion on Organovo Holdings, Inc. (NASDAQ:ONVO), with 2 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.75 average brokerage recommendation.